ICMR, National Institute of Malaria Research, New Delhi, 110 077, India.
HydroSciences Montpellier (HSM), University Montpellier, CNRS, IRD, 34093 Montpellier, France.
Acta Trop. 2021 Oct;222:106040. doi: 10.1016/j.actatropica.2021.106040. Epub 2021 Jul 10.
India is a malaria endemic country which is targeting malaria elimination by 2027. Transmission intensities are low-to-moderate depending on the region supported by multiple disease vectors. Among these, comparatively North-East India contributes to high proportions of malaria cases annually, the majority of which are due to Plasmodium falciparum (90%). Anopheles minimus and An. baimaii (sibling species in the An. dirus complex) are widely prevalent and incriminated as vectors of malaria. Number of intervention tools were field-evaluated beginning 1988 to date against disease vectors and causative parasites to contain the spread of malaria. These included (i) insecticide-treated netting materials (ITNs) for vector control, (ii) rapid diagnostic tests (RDTs) for in situ diagnosis, and (iii) therapeutic efficacy of artemisinin-based combination therapies (ACTs) for improved drug-policy; all of which were incorporated in healthcare services resulting in substantial disease transmission reduction. Populations of both An. minimus and An. baimaii were observed depleting, instead An. culicifacies s.l. recorded to be fast invading degraded forests and assessed to be resistant to multiple insecticides. Of the two prevalent Plasmodium species, while P. vivax continued to be susceptible to chloroquine therapy, P. falciparum had emerged resistant to most available antimalarial drugs except ACTs over space and time and spreading to peninsular India threatening elimination efforts. Disease transmission trends were observed to be declining for which the state of Assam has made huge strides reporting steady fall in cases each passing year vis-à-vis Meghalaya, Mizoram and Tripura (all sharing international border with Bangladesh), in which malaria transmission remained uninterrupted. Consequently, control of malaria in the North-East region of India is of immediate importance and needs prioritization for intensified disease surveillance and control interventions coupled with improved access to healthcare services mitigating risk of disease outbreaks and spread of drug-resistant malaria helping realize the goal of malaria elimination in the country.
印度是一个疟疾流行的国家,目标是在 2027 年消除疟疾。根据地区的不同,传播强度从低到中不等,有多种疾病媒介支持。在这些媒介中,相对而言,印度东北部每年贡献的疟疾病例比例较高,其中大部分是由恶性疟原虫(90%)引起的。微小按蚊和安蚊(安蚊属复杂种)广泛存在,并被认为是疟疾的传播媒介。自 1988 年以来,已经有多种干预工具在现场针对病媒和疟原虫进行了评估,以控制疟疾的传播。这些干预工具包括:(i)用于病媒控制的经杀虫剂处理的蚊帐材料(ITNs);(ii)用于现场诊断的快速诊断测试(RDTs);(iii)用于改善药物政策的青蒿素为基础的联合疗法(ACTs)的治疗效果;所有这些都被纳入医疗保健服务,从而大大减少了疾病的传播。微小按蚊和安蚊的种群数量都观察到减少,而安蚊库蚊复合体则记录到快速入侵退化森林,并被评估为对多种杀虫剂具有抗性。在两种流行的疟原虫中,虽然间日疟原虫仍然对氯喹治疗敏感,但恶性疟原虫在空间和时间上对大多数现有的抗疟药物(除了 ACTs 之外)产生了耐药性,并传播到印度半岛,威胁着消除努力。疾病传播趋势呈下降趋势,其中阿萨姆邦在报告病例方面取得了巨大进展,与梅加拉亚邦、米佐拉姆邦和特里普拉邦(都与孟加拉国接壤)相比,每年的病例数量都在稳步下降,在这些邦,疟疾传播仍未中断。因此,印度东北部地区的疟疾控制迫在眉睫,需要优先加强疾病监测和控制干预措施,并改善医疗保健服务的获取,以减轻疾病爆发和传播耐药性疟疾的风险,帮助实现该国消除疟疾的目标。